Lowering LDL-cholesterol through diet: Potential role in the statin era

Current Opinion in Lipidology

Volumn 22, Issue 1, 2011, Pages

  Bruckert, Eric ^a   Rosenbaum, David ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

cardiovascular diseases; cholesterol; diet; dietary fiber; omega 6; plant sterols; saturated fatty acid

Indexed keywords

ALPHA TOCOPHEROL; CAMPESTEROL; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; SITOSTEROL; SOYBEAN PROTEIN; STIGMASTEROL; TRIACYLGLYCEROL; VEGETABLE PROTEIN;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIET THERAPY; DIETARY FIBER; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MEDITERRANEAN DIET; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NUT; NUTRITIONAL ASSESSMENT; OBESITY; PLANTAGO OVATA; PREVALENCE; PRIORITY JOURNAL;

CHOLESTEROL, LDL; DIET; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; NUTS; PHYTOSTEROLS;

EID: 78751622912     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOL.0b013e328340b8e7     Document Type: Article

References (35)

1. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994; 308:367-372.
2. Cohen JC, Boerwinkle E, Mosley TH Jr, et al. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 2006; 354:1264-1272.
3. Ford ES, Ajani UA, Croft JB, etal. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007; 356:2388-2398.
4. Czernichow S, Thomas D, Bruckert E. n- 6 fatty acids and cardiovascular health: a review of the evidence for dietary intake recommendations. Br J Nutr 2010; 4:1-9.
5. Clarke R, Frost C, Collins R, et al. Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ 1997; 314:112-117.
6. Hodson L, Skeaff CM,Chisholm WA. The effect of replacing dietary saturated fat with polyunsaturated or monounsaturated fat on plasma lipids in free-living young adults. Eur J Clin Nutr 2001; 55:908-915.
7. Hu FB, Stampfer MJ, Manson JE, et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997; 337:1491-1499.
8. Remig V, Franklin B, Margolis S, etal. Trans fats in America: a review of their use, consumption, health implications, and regulation. J Am Diet Assoc 2010; 110:585-592.
9. Mozaffarian D, Aro A, Willett WC. Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr 2009; 63 (Suppl 2):S5-S21.
10. Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2010; 7:e1 000252.
11. Anderson JW, Baird P, Davis RH Jr, etal. Health benefits of dietary fiber. Nutr Rev 2009; 67:188-205.
12. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 1999; 69:30-42.
13. Anderson JW, Randles KM, Kendall CWC, Jenkins DJA. Carbohydrate and fiber recommendations for individuals with diabetes: a quantitative assessment and meta-analysis of the evidence. J Am Coll Nutr 2004; 23:5-17.
14. Sola R, Bruckert E, Valls RM, et al. Soluble fiber (Plantago ovata husk) reduces plasma low-density lipoprotein (LDL) cholesterol, triglycerides, insulin, oxidised LDL and systolic blood pressure in hypercholesterolaemic patients: a randomised trial. Atherosclerosis 2010; 211:630-637.
15. Salas-Salvado J, Farres X, Luque X, et al. Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial. Br J Nutr 2008; 99:1380-1387.
16. Whelton SP, Hyre AD, Pedersen B, Yi Y, etal. Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials. J Hypertens 2005; 23:475-481.
17. Ostlund RE Jr. Phytosterols and cholesterol metabolism. Curr Opin Lipidol 2004; 15:37-41.
18. Demonty I, Ras RT, van der Knaap HC, et al. Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake. J Nutr 2009; 139:271-284.
19. Sabate J, Oda K, Ros E. Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials. Arch Intern Med 2010; 170:821-827.
20. Banel DK, Hu FB. Effects of walnut consumption on blood lipids and other cardiovascular risk factors: a meta-analysis and systematic review. Am J Clin Nutr 2009; 90:56-63.
21. Anderson JW, Johnstone BM, Cook N. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995; 333:276-282.
22. Xiao CW. Health effects of soy protein and isoflavones in humans. J Nutr 2008; 138:S1244-S1249.
23. Taku K, Umegaki K, Sato Y, etal. Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr 2007; 85:1148-1156.
24. Jenkins DJ, Kendall CW, Marchie A, et al. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA 2003; 290:502-510.
25. Jenkins DJ, Kendall CW, Marchie A, et al. Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants. Am J Clin Nutr 2005; 81:380-387.
26. Jenkins DJ, Kendall CW, Faulkner DA, et al. Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. Am J Clin Nutr 2006; 83:582-591.
27. Sofi F, Cesari F, Abbate R, et al. Adherence to Mediterranean diet and health status: meta-analysis. BMJ 2008; 337:a1344.
28. Giugliano D, Esposito K. Mediterranean diet and metabolic diseases. Curr Opin Lipidol 2008; 19:63-68.
29. Esposito K, Ciotola M, Giugliano D. Mediterranean diet, endothelial function and vascular inflammatory markers. Public Health Nutr 2006; 9 (8A):1073-1076.
30. Vaquero MP, Sanchez Muniz FJ, Jimenez Redondo S, et al. Major diet-drug interactions affecting the kinetic characteristics and hypolipidaemic proper ties of statins. Nutr Hosp 2010; 25:93-206.
31. Saravanan P, Davidson NC, Schmidt EB, Calder PC. Cardiovascular effects of marine omega-3 fatty acids. Lancet 2010; 376:540-550.
32. Filion KB, El Khoury F, Bielinski M, et al. Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord 2010; 3:10-24.
33. Yokoyama M, Origasa H, Matsuzaki M, et al., Japan EPA Lipid Intervention Study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007; 369:1090-1098.
34. Leon H, Shibata MC, Sivakumaran S, et al. Effect of fish oil on arrhythmias and mortality: systematic review. BMJ 2008; 337:a2931.
35. Kromhout D, Giltay EJ, Geleijnse JM for the Alpha Omega Trial Group. n-3 fatty acids and cardiovascular events after myocardial infarction. New Engl J Med 2010.